InvestorsHub Logo
icon url

biopharm

02/21/18 1:49 PM

#325019 RE: hutschi #325018

PS, It's Complicated: The Roles of Phosphatidylserine and Phosphatidylethanolamine in..



It's complicated ? Hmm, ROTH opinion report must not have found it to be complicated at all...

Just find a couple so called experts that say they also see residual value "as of now" and yes, it is not fully understood so the fair opinion would be happy with a back loaded deal with Breadcrumb $8M upfront (not even uofront....but over 8 months) ...

Has anyone got an answer from ROTH in why they did not seek more expert witness / KOLs for the valuation in the IP held by Peregrine Pharmaceuticals....now CDMO ?

Why and how ? It looks like any challenge upon CDMO BODs will be met with "well ROTH gave us this opinion..." and they received the opinion from who ? Lol

Some interesting stuff and will ROTH now be bought out next ? It would not surprise me one bit